The Oncology Institute Announces Third Quarter 2022 Earnings Release Date and Conference Call
The Oncology Institute (TOI) announced it will release its third quarter financial results on November 9, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
The Oncology Institute (TOI) announced it will release its third quarter financial results on November 9, 2022, after market close. The results will be followed by a conference call at 5:00 p.m. Eastern Time. Investors can access the call via phone or live webcast through the company's Investor Relations website. Founded in 2007, TOI provides value-based oncology care to approximately 1.7 million patients, supported by over 90 clinicians across 50 clinic locations. For further information, visit their official website.
Positive
- Company provides oncology care to approximately 1.7 million patients.
- TOI has over 90 employed clinicians and 700+ staff.
- Continuous expansion with more than 50 clinic locations.
Negative
- None.
Details
News Market Reaction – TOI
The recorded move for TOI in the trading session of this news was +0.64%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CERRITOS, Calif., Oct. 19, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its third quarter results after the market close on Wednesday November 9, 2022, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).
The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13732555. The replay will be available until November 16, 2022.
Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.
About The Oncology Institute
Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.7 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 90+ employed clinicians and more than 700 teammates in over 50 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.
Contacts
Media
The Oncology Institute
Julie Korinke
juliekorinke@theoncologyinstitute.com
(562) 735-3226 x 88806
Juan Lezama
juanlezama@theoncologyinstitute.com
(562) 374-8434
Investors
Solebury Strategic Communications
Maria Lycouris
investors@theoncologyinstitute.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.